[go: up one dir, main page]

WO2008096730A1 - Agent anti-inflammatoire et son utilisation - Google Patents

Agent anti-inflammatoire et son utilisation Download PDF

Info

Publication number
WO2008096730A1
WO2008096730A1 PCT/JP2008/051818 JP2008051818W WO2008096730A1 WO 2008096730 A1 WO2008096730 A1 WO 2008096730A1 JP 2008051818 W JP2008051818 W JP 2008051818W WO 2008096730 A1 WO2008096730 A1 WO 2008096730A1
Authority
WO
WIPO (PCT)
Prior art keywords
inflammatory agent
inflammatory
effect
agent
exhibit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/051818
Other languages
English (en)
Japanese (ja)
Inventor
Kazuhiro Ishiguro
Hidemi Gotoh
Takahumi Andoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nagoya University NUC
Original Assignee
Nagoya University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagoya University NUC filed Critical Nagoya University NUC
Priority to JP2008557111A priority Critical patent/JPWO2008096730A1/ja
Publication of WO2008096730A1 publication Critical patent/WO2008096730A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un nouvel agent anti-inflammatoire et l'utilisation de l'agent anti-inflammatoire. De façon spécifique, l'invention concerne un agent anti-inflammatoire comprenant de l'acide acétique ou un sel de celui-ci comme composant principal. L'agent anti-inflammatoire peut présenter son effet anti-inflammatoire grâce à l'inhibition spécifique de l'activation d'un facteur de transcription NFAT. Lorsque l'agent anti-inflammatoire est utilisé en combinaison avec un agent anti-inflammatoire stéroïdien, un effet thérapeutique supérieur peut être obtenu.
PCT/JP2008/051818 2007-02-09 2008-02-05 Agent anti-inflammatoire et son utilisation Ceased WO2008096730A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008557111A JPWO2008096730A1 (ja) 2007-02-09 2008-02-05 抗炎症剤及びその用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-030067 2007-02-09
JP2007030067 2007-02-09

Publications (1)

Publication Number Publication Date
WO2008096730A1 true WO2008096730A1 (fr) 2008-08-14

Family

ID=39681639

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/051818 Ceased WO2008096730A1 (fr) 2007-02-09 2008-02-05 Agent anti-inflammatoire et son utilisation

Country Status (2)

Country Link
JP (1) JPWO2008096730A1 (fr)
WO (1) WO2008096730A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017198701A1 (fr) * 2016-05-17 2017-11-23 Proponent Biotech Gmbh Acides carboxyliques pour le traitement/la prévention d'une maladie de la peau
EP3950049A1 (fr) * 2015-04-24 2022-02-09 Galvani Bioelectronics Limited Utilisation d'un agent anti-inflammatoire

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05112422A (ja) * 1991-10-21 1993-05-07 Noevir Co Ltd 皮膚化粧料及び皮膚外用剤
JP2003238399A (ja) * 2002-02-20 2003-08-27 Shiono Koryo Kk ヒアルロニダーゼ活性阻害剤、これを含有する香料組成物、飲食品及び化粧品。
WO2005027893A1 (fr) * 2003-09-19 2005-03-31 Otsuka Pharmaceutical Co., Ltd. Promoteur de secretion de $g(b)-defensine
JP2006143652A (ja) * 2004-11-19 2006-06-08 Meiji Milk Prod Co Ltd 炎症性腸疾患治療薬

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05112422A (ja) * 1991-10-21 1993-05-07 Noevir Co Ltd 皮膚化粧料及び皮膚外用剤
JP2003238399A (ja) * 2002-02-20 2003-08-27 Shiono Koryo Kk ヒアルロニダーゼ活性阻害剤、これを含有する香料組成物、飲食品及び化粧品。
WO2005027893A1 (fr) * 2003-09-19 2005-03-31 Otsuka Pharmaceutical Co., Ltd. Promoteur de secretion de $g(b)-defensine
JP2006143652A (ja) * 2004-11-19 2006-06-08 Meiji Milk Prod Co Ltd 炎症性腸疾患治療薬

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PATZ J. ET AL.: "Treatment of refractory distal ulcerative colitis with short chain fatty acid enemas", AMERICAN JOURNAL OF GASTROENTEROLOGY, vol. 91, no. 4, 1996, pages 731 - 734 *
VERNIA P. ET AL.: "Short-chain fatty acid topical treatment in distal ulcerative colitis", ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 9, no. 3, 1995, pages 309 - 313 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3950049A1 (fr) * 2015-04-24 2022-02-09 Galvani Bioelectronics Limited Utilisation d'un agent anti-inflammatoire
WO2017198701A1 (fr) * 2016-05-17 2017-11-23 Proponent Biotech Gmbh Acides carboxyliques pour le traitement/la prévention d'une maladie de la peau
CN109152753A (zh) * 2016-05-17 2019-01-04 拥护者生物技术有限公司 用于治疗/预防皮肤病的羧酸

Also Published As

Publication number Publication date
JPWO2008096730A1 (ja) 2010-05-20

Similar Documents

Publication Publication Date Title
WO2008133982A3 (fr) Timbre adhésif contenant un agent aversif
IL212560A0 (en) Combination of an oxidant and a photoactivator for the healing of wounds
WO2010119423A3 (fr) Compositions cosmétiques comprenant de l'oridonine et nouvelles utilisations cosmétiques
WO2009067856A8 (fr) Inhibiteur de l'histone désacétylase, composition et utilisation de celui-ci
WO2007115821A3 (fr) Composés organiques
WO2007103719A3 (fr) MODULATEURS DE LA 11-β-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE DE TYPE 1, LEURS COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCÉDÉS D'UTILISATION
WO2007115305A3 (fr) Formes de dosage orales incluant un inhibiteur de l'agrégation plaquettaire et un inhibiteur acide
EP2467173B8 (fr) Pansements, procédés d'utilisation de ceux-ci et procédés de formation de ceux-ci
WO2010060937A3 (fr) Combinaisons inhibitrices hsp90
WO2008089087A3 (fr) Composition de type comprimé-dans-comprimé
WO2008057780A3 (fr) Administration transdermique de dérivés polaires de kétoprofène
AU2008303948A8 (en) Use of the peptide Asn-Asp-Asp-Cys-Glu- Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu alone or in combination with the peptide Thr-Thr-Ser-Gln-Val- Arg-Pro-Arg as a therapeutic agent
WO2008070116A3 (fr) Compositions topiques pour le traitement de maladies de peau
WO2009005891A3 (fr) Ruban adhesif amovible a tirette repliable
WO2008046603A3 (fr) Autocollant comportant un agent d'amertume et des agents fluidifiants des sécrétions naturelles des voies respiratoires
IL193155A0 (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
WO2008101195A3 (fr) Inversion de la résistance à des médicaments dans une maladie néoplasique
WO2009053980A3 (fr) Coupe-faim amélioré
WO2012037193A3 (fr) Formulations de traitement au glucosinolate
WO2008096730A1 (fr) Agent anti-inflammatoire et son utilisation
CR11869A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
WO2008029414A3 (fr) Utilisation d'un inhibiteur du facteur de transcription dans la fabrication d'un médicament
BRPI0914462A2 (pt) "composição tópica, método de prevenção ou redução da ocorrência de tratamento de acne e uso de uma composição"
WO2007108004A8 (fr) Derives du s-alkylisothiouronium pour le traitement de maladies inflammatoires
WO2009129205A3 (fr) Activité anti-inflammatoire de sparc et utilisations de cette dernière

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08704445

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2008557111

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08704445

Country of ref document: EP

Kind code of ref document: A1